EMIT 2000 Mycophenolic Acid Assay*

MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The EMIT® 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.


  • Results available within 10 minutes
  • Utilizes plasma samples - no pretreatment required
  • Assay can be performed alongside 3 other immunosuppressive drugs
  • Correlates to the HPLC reference method



  • Streamlined ISD monitoring for enhanced productivity
  • Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system


EMIT 2000 MPA Assay

Product Code


Sample Type

EDTA or Heparinized plasma



Reportable Range

0.1 μg/mL–15 μg/mL


With new reagent lot

Reagent Stability

Opened - until expiration date

Learn more about the V-Twin® and Viva-E® Drug Testing Systems

Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.